$NAOV
NanoVibronix, Inc.

2016 Q1 Form 10-K Financial Statement

#000114420416091141 Filed on March 30, 2016

View on sec.gov

Income Statement

Concept 2016 Q1 2015 2014 Q4
Revenue $57.00K $147.0K $50.00K
YoY Change 90.0% -27.59% 400.0%
Cost Of Revenue $27.00K $49.00K $10.00K
YoY Change 170.0% -47.31% 0.0%
Gross Profit $30.00K $98.00K $40.00K
YoY Change 50.0% -10.91%
Gross Profit Margin 52.63% 66.67% 80.0%
Selling, General & Admin $390.0K $1.123M $170.0K
YoY Change 62.5% 26.18% 142.86%
% of Gross Profit 1300.0% 1145.92% 425.0%
Research & Development $114.0K $399.0K $150.0K
YoY Change 14.0% -7.42% 25.0%
% of Gross Profit 380.0% 407.14% 375.0%
Depreciation & Amortization $2.000K $9.000K $0.00
YoY Change 0.0% 0.0%
% of Gross Profit 6.67% 9.18% 0.0%
Operating Expenses $114.0K $1.522M $320.0K
YoY Change -65.45% 15.22% 68.42%
Operating Profit -$84.00K -$1.424M -$280.0K
YoY Change -72.9% 17.59% 47.37%
Interest Expense -$10.00K -$1.410M -$500.0K
YoY Change -96.88% 0.71% 28.21%
% of Operating Profit
Other Income/Expense, Net -$20.00K
YoY Change -300.0%
Pretax Income -$490.0K -$2.856M -$780.0K
YoY Change -22.22% 9.93% 44.44%
Income Tax $10.00K $28.00K $20.00K
% Of Pretax Income
Net Earnings -$495.0K -$2.884M -$800.0K
YoY Change -21.43% 8.95% 37.93%
Net Earnings / Revenue -868.42% -1961.9% -1600.0%
Basic Earnings Per Share
Diluted Earnings Per Share -$190.8K -$1.455M -$5.000M
COMMON SHARES
Basic Shares Outstanding 2.624M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2016 Q1 2015 2014 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.280M $1.610M
YoY Change -54.29% 1688.89%
Cash & Equivalents $1.278M $1.610M $90.00K
Short-Term Investments
Other Short-Term Assets $50.00K $50.00K
YoY Change 150.0%
Inventory $80.00K $70.00K $35.00K
Prepaid Expenses $0.00
Receivables $10.00K $40.00K $21.00K
Other Receivables $0.00 $0.00
Total Short-Term Assets $1.420M $1.780M $165.0K
YoY Change -50.35% 947.06% -25.0%
LONG-TERM ASSETS
Property, Plant & Equipment $20.00K $10.00K $18.00K
YoY Change 0.0% -50.0% -10.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $220.0K $200.0K
YoY Change 22.22% -62.96%
Total Long-Term Assets $231.0K $200.0K $558.0K
YoY Change 21.58% -63.64% 18.72%
TOTAL ASSETS
Total Short-Term Assets $1.420M $1.780M $165.0K
Total Long-Term Assets $231.0K $200.0K $558.0K
Total Assets $1.651M $1.980M $723.0K
YoY Change -45.87% 175.0% 4.78%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $43.00K $60.00K $101.0K
YoY Change -52.22% -40.0% 405.0%
Accrued Expenses $140.0K $551.0K
YoY Change -77.42%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $329.0K $300.0K $5.420M
YoY Change -82.95% -94.46% 52.25%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.930M $1.900M
YoY Change 116.85% 106.52%
Total Long-Term Liabilities $1.928M $1.900M $919.0K
YoY Change 116.63% 106.52% 113.72%
TOTAL LIABILITIES
Total Short-Term Liabilities $329.0K $300.0K $5.420M
Total Long-Term Liabilities $1.928M $1.900M $919.0K
Total Liabilities $2.257M $2.190M $6.339M
YoY Change -19.96% -65.46% 58.87%
SHAREHOLDERS EQUITY
Retained Earnings $11.00K -$16.85M
YoY Change
Common Stock $2.000K $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$606.0K -$210.0K -$5.616M
YoY Change
Total Liabilities & Shareholders Equity $1.651M $1.980M $723.0K
YoY Change -45.87% 175.0% 4.78%

Cashflow Statement

Concept 2016 Q1 2015 2014 Q4
OPERATING ACTIVITIES
Net Income -$495.0K -$2.884M -$800.0K
YoY Change -21.43% 8.95% 37.93%
Depreciation, Depletion And Amortization $2.000K $9.000K $0.00
YoY Change 0.0% 0.0%
Cash From Operating Activities -$360.0K -$1.480M -$250.0K
YoY Change 20.0% 64.44% 66.67%
INVESTING ACTIVITIES
Capital Expenditures $7.000K $1.000K $0.00
YoY Change -75.0% -100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$10.00K $0.00 $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 30.00K 3.010M 300.0K
YoY Change -99.0% 234.44% 50.0%
NET CHANGE
Cash From Operating Activities -360.0K -1.480M -250.0K
Cash From Investing Activities -10.00K 0.000 0.000
Cash From Financing Activities 30.00K 3.010M 300.0K
Net Change In Cash -340.0K 1.530M 50.00K
YoY Change -112.55% 25.0%
FREE CASH FLOW
Cash From Operating Activities -$360.0K -$1.480M -$250.0K
Capital Expenditures $7.000K $1.000K $0.00
Free Cash Flow -$367.0K -$1.481M -$250.0K
YoY Change 22.33% 63.83% 78.57%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5000 USD
CY2015Q4 us-gaap Deferred Costs
DeferredCosts
0 USD
CY2014Q4 us-gaap Deferred Costs
DeferredCosts
358000 USD
CY2015Q4 nvbxu Severance Assets Noncurent
SeveranceAssetsNoncurent
197000 USD
CY2014Q4 nvbxu Severance Assets Noncurent
SeveranceAssetsNoncurent
182000 USD
CY2015Q4 us-gaap Assets
Assets
1983000 USD
CY2014Q4 us-gaap Assets
Assets
723000 USD
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
58000 USD
CY2015Q4 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
239000 USD
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
21000 USD
CY2015Q4 us-gaap Assets Current
AssetsCurrent
1776000 USD
CY2014Q4 us-gaap Assets Current
AssetsCurrent
165000 USD
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
18000 USD
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1614000 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
90000 USD
CY2015Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
86000 USD
CY2014Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
19000 USD
CY2015Q4 us-gaap Inventory Net
InventoryNet
71000 USD
CY2014Q4 us-gaap Inventory Net
InventoryNet
35000 USD
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10000 USD
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
101000 USD
CY2015Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
1696000 USD
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5420000 USD
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
2000 USD
CY2015 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2884000 USD
CY2014 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2647000 USD
CY2014 us-gaap Operating Expenses
OperatingExpenses
1321000 USD
CY2014 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
1387000 USD
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2598000 USD
CY2015 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
28000 USD
CY2014Q4 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
702000 USD
CY2015Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
0 USD
CY2014Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
4617000 USD
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
297000 USD
CY2014Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
734000 USD
CY2015Q4 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
199000 USD
CY2014Q4 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
185000 USD
CY2015Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1895000 USD
CY2014Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
919000 USD
CY2015Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
19521000 USD
CY2014Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
11234000 USD
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-19734000 USD
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-16850000 USD
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
-209000 USD
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
-5616000 USD
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1983000 USD
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
723000 USD
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
USD
CY2015 us-gaap Revenues
Revenues
147000 USD
CY2014 us-gaap Revenues
Revenues
203000 USD
CY2015 us-gaap Cost Of Revenue
CostOfRevenue
49000 USD
CY2014 us-gaap Cost Of Revenue
CostOfRevenue
93000 USD
CY2015 us-gaap Gross Profit
GrossProfit
98000 USD
CY2014 us-gaap Gross Profit
GrossProfit
110000 USD
CY2015 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
399000 USD
CY2014 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
431000 USD
CY2015 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
377000 USD
CY2014 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
301000 USD
CY2015 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
747000 USD
CY2014 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
589000 USD
CY2015 us-gaap Operating Expenses
OperatingExpenses
1523000 USD
CY2015 us-gaap Operating Income Loss
OperatingIncomeLoss
-1424000 USD
CY2014 us-gaap Operating Income Loss
OperatingIncomeLoss
-1211000 USD
CY2015 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
1432000 USD
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2856000 USD
CY2014 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
49000 USD
CY2015 us-gaap Net Income Loss
NetIncomeLoss
-2884000 USD
CY2014 us-gaap Net Income Loss
NetIncomeLoss
-2647000 USD
CY2015 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.46
CY2014 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-17.08
CY2015 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1978395 shares
CY2014 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
155009 shares
CY2015 us-gaap Depreciation
Depreciation
9000 USD
CY2014 us-gaap Depreciation
Depreciation
9000 USD
CY2015 us-gaap Share Based Compensation
ShareBasedCompensation
220000 USD
CY2014 us-gaap Share Based Compensation
ShareBasedCompensation
24000 USD
CY2015 us-gaap Debt Instrument Convertible Beneficial Conversion Feature
DebtInstrumentConvertibleBeneficialConversionFeature
-384000 USD
CY2014 us-gaap Debt Instrument Convertible Beneficial Conversion Feature
DebtInstrumentConvertibleBeneficialConversionFeature
-885000 USD
CY2015 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
962000 USD
CY2014 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
138000 USD
CY2015 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-16000 USD
CY2014 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
8000 USD
CY2015 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
67000 USD
CY2014 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-33000 USD
CY2014 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-31000 USD
CY2015 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-43000 USD
CY2015 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
36000 USD
CY2015 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1000 USD
CY2014 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4000 USD
CY2015 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-1000 USD
CY2014 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
83000 USD
CY2015 us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
-105000 USD
CY2014 us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
183000 USD
CY2015 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-1000 USD
CY2014 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-2000 USD
CY2015 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
65000 USD
CY2014 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
372000 USD
CY2015 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-1480000 USD
CY2014 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-900000 USD
CY2014 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-4000 USD
CY2015 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
3005000 USD
CY2015 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 USD
CY2014 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
900000 USD
CY2015 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
3005000 USD
CY2014 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
900000 USD
CY2015 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1524000 USD
CY2014 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-4000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
94000 USD
CY2015 us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
0 USD
CY2014 us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
86000 USD
CY2015 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
5066000 USD
CY2014 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
0 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
-3297000 USD
CY2014 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
24000 USD
CY2014 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
314000 USD
CY2014 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-2647000 USD
CY2015 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
511000 USD
CY2015 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
1964000 USD
CY2015 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
446000 USD
CY2015 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
1359000 USD
CY2015 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
2101000 USD
CY2015 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
220000 USD
CY2015 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-2884000 USD
CY2015 us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
0 USD
CY2015 nvbxu Debt Conversion Converted Instrument Amount3
DebtConversionConvertedInstrumentAmount3
1606000 USD
CY2015 nvbxu Preferred Stock Issued During Period Value Issued For Services
PreferredStockIssuedDuringPeriodValueIssuedForServices
0 USD
CY2015 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
0 USD
CY2015 nvbxu Warrants Issued During Period Vaue
WarrantsIssuedDuringPeriodVaue
84000 USD
CY2014Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
563910 shares
CY2014Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
2.66
CY2015 dei Document Type
DocumentType
10-K
CY2015 dei Amendment Flag
AmendmentFlag
false
CY2015 dei Document Period End Date
DocumentPeriodEndDate
2015-12-31
CY2015 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
CY2015 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2015 dei Entity Registrant Name
EntityRegistrantName
NanoVibronix, Inc.
CY2015 dei Entity Central Index Key
EntityCentralIndexKey
0001326706
CY2015 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2015 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2015 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2015 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2015 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2015Q2 dei Entity Public Float
EntityPublicFloat
2200000 USD
CY2015 dei Trading Symbol
TradingSymbol
NVBXU
CY2016Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
2623710 shares
CY2015 nvbxu Preferred Stock Issued During Period Shares Issued For Services
PreferredStockIssuedDuringPeriodSharesIssuedForServices
0 shares
CY2014 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
0 USD
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
24000000 shares
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
24000000 shares
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2611328 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
163580 shares
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2611328 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
163580 shares
CY2015Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
4760000 USD
CY2004Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2014Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2014Q1 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
714286 shares
CY2014Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2015 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: -28.35pt; MARGIN: 0pt 0px 0pt 85.05pt; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <table style="MARGIN-TOP: 0pt; WIDTH: 100%; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 56.7pt"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="WIDTH: 28.35pt"> <div style="CLEAR:both;CLEAR: both"><font style="FONT-SIZE: 10pt"> r.</font></div> </td> <td style="TEXT-ALIGN: justify"> <div style="CLEAR:both;CLEAR: both"><font style="FONT-SIZE: 10pt"> Concentrations of credit risk:</font></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 85.05pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">Financial instruments that potentially subject the Company and its subsidiary to concentrations of credit risk consist principally of cash and cash equivalents and trade receivables.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 85.05pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 85.05pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">Cash and cash equivalents are invested in major banks in the United States and Israel. Such deposits in the United States and in Israel may be in excess of insured limits and are not insured in other jurisdictions. Management believes that the financial institutions that hold the Company&#8217;s investments are financially sound and, accordingly, minimal credit risk exists with respect to these investments.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: -56.7pt; MARGIN: 0pt 0px 0pt 56.7pt; FONT: 10pt Times New Roman, Times, Serif" align="justify"><b>&#160;</b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 85.05pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">Trade receivables are mainly derived from sales to customers, located in the United States, Israel, Europe and India. The Company performs ongoing credit evaluation of its customers and to date has not experienced any material losses.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 85.05pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company and its subsidiary have no off-balance-sheet concentration of credit risk such as foreign exchange contracts, option contracts or other foreign hedging arrangements.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2015Q4 us-gaap Inventory Write Down
InventoryWriteDown
8000 USD
CY2014Q4 us-gaap Inventory Write Down
InventoryWriteDown
14000 USD
CY2014 us-gaap Severance Costs1
SeveranceCosts1
43000 USD
CY2015Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
50000 USD
CY2014Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
0 USD
CY2015Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
36000 USD
CY2014Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
19000 USD
CY2015Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
110000 USD
CY2014Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
109000 USD
CY2015Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
100000 USD
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
91000 USD
CY2014 us-gaap Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
0.0067 pure
CY2015Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
4750000 USD
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
250404 shares
CY2014Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
3886000 USD
CY2015Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
10000 USD
CY2014Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
10000 USD
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2015Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
4760000 USD
CY2014Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
3896000 USD
CY2015Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
30000 USD
CY2015Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
15000 USD
CY2015Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
45000 USD
CY2015 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
35000 USD
CY2014 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
77000 USD
CY2015 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2884000 USD
CY2014 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2647000 USD
CY2015 us-gaap Fair Value Assumptions Expected Dividend Rate
FairValueAssumptionsExpectedDividendRate
0 pure
CY2014 us-gaap Fair Value Assumptions Expected Dividend Rate
FairValueAssumptionsExpectedDividendRate
0 pure
CY2014 us-gaap Fair Value Assumptions Expected Volatility Rate
FairValueAssumptionsExpectedVolatilityRate
0.63 pure
CY2014Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
3896000 USD
CY2015Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2014Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
2203000 USD
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
1821000 USD
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
644000 USD
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
777000 USD
CY2014Q2 nvbxu Percentage Of Beneficial Ownership Of Common Stock
PercentageOfBeneficialOwnershipOfCommonStock
0.0999 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation Deductions Dividends
EffectiveIncomeTaxRateReconciliationDeductionsDividends
0.2 pure
CY2015 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.265 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.265 pure
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0 pure
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.6 pure
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0 pure
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0173 pure
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P0Y
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P10Y
CY2015Q1 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
3150000 USD
CY2015Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
13651 USD
CY2015 us-gaap Operating Loss Carryforwards Limitations On Use
OperatingLossCarryforwardsLimitationsOnUse
The federal operating loss can be offset against taxable income for 20 years.
CY2011 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.15 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.125 pure
CY2012 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.15 pure
CY2015 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.125 pure
CY2015 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.15 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation Deductions Extraterritorial Income Exclusion
EffectiveIncomeTaxRateReconciliationDeductionsExtraterritorialIncomeExclusion
0.16 pure
CY2015 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
220000 USD
CY2014 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
24000 USD
CY2015 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
seven (7) for one (1) (i.e., seven shares of Common stock, $ 0.001 nominal value each, will be combined into one share of Common stock $ 0.001 nominal value).
CY2015Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
3005000 USD
CY2015Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
145000 USD
CY2015Q1 us-gaap Equity Method Investment Aggregate Cost
EquityMethodInvestmentAggregateCost
3150000 USD
CY2015Q1 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
333959 shares
CY2011Q4 nvbxu Warrants Issued To Puchase Of Common Stock Shares
WarrantsIssuedToPuchaseOfCommonStockShares
2319062 shares
nvbxu Warrants Issued To Puchase Of Common Stock Shares
WarrantsIssuedToPuchaseOfCommonStockShares
563910 shares
CY2004Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
400000 shares
CY2015Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
95000 USD
CY2014Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
67000 USD
CY2015Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
47000 USD
CY2014Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
551000 USD
CY2015Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
97000 USD
CY2014Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
84000 USD
CY2015Q4 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
239000 USD
CY2014Q4 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
702000 USD
CY2015 us-gaap Other Nonrecurring Income Expense
OtherNonrecurringIncomeExpense
21000 USD
CY2014 us-gaap Other Nonrecurring Income Expense
OtherNonrecurringIncomeExpense
-8000 USD
CY2015Q4 nvbxu Contingent Obligation To Royalty
ContingentObligationToRoyalty
492000 USD
CY2014 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
0 USD
CY2015 us-gaap Interest Expense Debt
InterestExpenseDebt
65000 USD
CY2014 us-gaap Interest Expense Debt
InterestExpenseDebt
372000 USD
CY2015 us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0in; MARGIN: 0pt 0px 0pt 56.7pt; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt" align="left"> <table style="MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0" width="100%"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 56.7pt"> <div style="CLEAR:both;CLEAR: both"></div> </td> <td style="WIDTH: 28.35pt"> <div style="CLEAR:both;CLEAR: both">a.</div> </td> <td style="TEXT-ALIGN: justify"> <div style="CLEAR:both;CLEAR: both">Use of estimates:</div> </td> </tr> </table> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0in; MARGIN: 0pt 0px 0pt 85.05pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2015 us-gaap Severance Costs1
SeveranceCosts1
32000 USD

Files In Submission

Name View Source Status
0001144204-16-091141-index-headers.html Edgar Link pending
0001144204-16-091141-index.html Edgar Link pending
0001144204-16-091141.txt Edgar Link pending
0001144204-16-091141-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
nvbxu-20151231.xml Edgar Link completed
nvbxu-20151231.xsd Edgar Link pending
nvbxu-20151231_cal.xml Edgar Link unprocessable
nvbxu-20151231_def.xml Edgar Link unprocessable
nvbxu-20151231_lab.xml Edgar Link unprocessable
nvbxu-20151231_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tfin.jpg Edgar Link pending
tpg10.jpg Edgar Link pending
tpg11a.jpg Edgar Link pending
tpg11b.jpg Edgar Link pending
tpg15.jpg Edgar Link pending
tpg18.jpg Edgar Link pending
tpg8.jpg Edgar Link pending
v434972_10k.htm Edgar Link pending
v434972_ex31-1.htm Edgar Link pending
v434972_ex31-2.htm Edgar Link pending
v434972_ex32-1.htm Edgar Link pending
v434972_ex32-2.htm Edgar Link pending